The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Compounded "semaglutide" is not FDA approved semaglutide.com FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure